Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

479 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of sacubitril/valsartan according to background beta-blocker therapy in patients with heart failure and reduced ejection fraction: Insights from PARADIGM-HF.
Gupta SD, Butt JH, McMurray EGM, Talebi A, Matsumoto S, Rizkala AR, Henderson AD, Desai AS, Lefkowitz M, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Jhund PS, McMurray JJV; PARADIGM‐HF Investigators and Committees. Gupta SD, et al. Among authors: zile mr. Eur J Heart Fail. 2024 Nov 19. doi: 10.1002/ejhf.3515. Online ahead of print. Eur J Heart Fail. 2024. PMID: 39563094
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity.
Packer M, Zile MR, Kramer CM, Baum SJ, Litwin SE, Menon V, Ge J, Weerakkody GJ, Ou Y, Bunck MC, Hurt KC, Murakami M, Borlaug BA; SUMMIT Trial Study Group. Packer M, et al. Among authors: zile mr. N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2410027. Online ahead of print. N Engl J Med. 2024. PMID: 39555826
Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.
Shen L, Dewan P, Ferreira JP, Cunningham JW, Jhund PS, Anand IS, Chandra A, Chiang LM, Claggett B, Desai AS, Gong J, Lam CSP, Lefkowitz MP, Maggioni AP, Martinez F, Packer M, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Solomon SD, McMurray JJV. Shen L, et al. Among authors: zile mr. Circulation. 2024 Oct 21. doi: 10.1161/CIRCULATIONAHA.124.070553. Online ahead of print. Circulation. 2024. PMID: 39429145
Personalized Intervention Strategy Based on a Risk Score Generated From Subcutaneous Insertable Cardiac Monitor: Results From Phase 1 of ALLEVIATE-HF.
Kahwash R, Zile MR, Chalasani P, Bertolet B, Gravelin L, Khan MS, Wehking J, Van Dorn B, Sarkar S, Laager V, Gerritse B, Laechelt A, Butler J; ALLEVIATE‐HF Phase I Investigators. Kahwash R, et al. Among authors: zile mr. J Am Heart Assoc. 2024 Oct 15;13(20):e035501. doi: 10.1161/JAHA.124.035501. Epub 2024 Oct 11. J Am Heart Assoc. 2024. PMID: 39392161 Free article. Clinical Trial.
Natriuretic Peptides, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
Neuen BL, Vaduganathan M, Claggett BL, Beldhuis I, Myhre P, Desai AS, Skali H, Mc Causland FR, McGrath M, Anand I, Zile MR, Pfeffer MA, McMurray JJV, Solomon SD. Neuen BL, et al. Among authors: zile mr. JACC Heart Fail. 2024 Aug 31:S2213-1779(24)00610-3. doi: 10.1016/j.jchf.2024.08.009. Online ahead of print. JACC Heart Fail. 2024. PMID: 39365237 Free article.
Asymptomatic vs Symptomatic Hypotension With Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction in PARADIGM-HF.
Matsumoto S, Shen L, Henderson AD, Böhm M, Desai AS, Køber L, Lefkowitz MP, Packer M, Rouleau JL, Solomon SD, Swedberg K, Vaduganathan M, Vardeny O, Voors AA, Zile MR, Jhund PS, McMurray JJV. Matsumoto S, et al. Among authors: zile mr. J Am Coll Cardiol. 2024 Oct 29;84(18):1685-1700. doi: 10.1016/j.jacc.2024.08.012. Epub 2024 Sep 25. J Am Coll Cardiol. 2024. PMID: 39320292 Clinical Trial.
479 results